Muscular dystrophy (MD) is a disease characterized by progressive skeletal muscle weakness, defects in muscle proteins (dystrophin concentration is greatly reduced), and the death of muscle cells and tissue. Diagnosis is based on muscle biopsy, laboratory evaluation (increased levels of creatine phosphokinase) and EMG findings. There are nine major types of muscular dystrophy and most types of muscular dystrophy are multi-system disorders with manifestations in body systems including the heart, gastrointestinal system, nervous system, endocrine glands, eyes, and brain. MD has a strong genetic link. Options are limited for treating. There has been a keen interest in using stem cells to regenerate muscle tissue and there has been success in using human stem cells for MD in mice. There is hope that adipose derived stem cells may be effective in regenerating muscle damaged by MD. There are therapies that are still being researched to optimize the use of stem cells in treating muscular dystrophy. There is a variety of methods that are being tested in treating the disorder. Scientists hope that in the very near future stem cell therapy will be used towards the cure for MD.
Muscular Dystrophy – Gulf Coast Stem Cell & Regenerative Medicine Center
Being an affiliate member of the Cell Surgical Network(CSN,) Gulf Coast Stem Cell & Regenerative Medicine Center(GCSC&RMC) uses specific SVF protocols that attempt to utilize the potential regenerative properties of SVF (rich in mesenchymal stem cells and growth factors). SVF is systemically deployed and is expected to hone to damaged areas preferentially. This is all done as an outpatient at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately three hours.
We at GCSC&RMC care about our patients and understand their difficulties. We take pride in the time we spend caring for them and deploying, what we believe is the best protocol to help them achieve their goals.
By filling the out the Contact Form herewith, we would have the opportunity of addressing any questions and concerns about our methodology and protocols for Muscular Dystrophy.